Рифат Сафади

Должность: Гепатолог
Языки: Английский, Иврит
Принимает: только взрослых



Профессор Рифат Сафади

Образование

Родился 24-го января 1965 года. Выпускник Еврейского университета (1999 г). Проходил ординатуру в отделении общей терапии а затем при отделении гастроэнтерологии университетской клиники "Хадасса".

Специализация

Заведующий центром гепатологии.

Профессиональная деятельность

Член комитета по развитию центра трансплантации соматических клеток Старший врач в отделении лечения заболеваний печени Член Американской и Европейской ассоциаций по изучению печени Автор многочисленных научных публикаций.

Научные публикации

Nebokitug, an anti-CCL24 monoclonal antibody, in patients with primary sclerosing cholangitis: A phase 2 study
Adjunctive Semaglutide in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Cardiovascular Assessments in Children and Adolescents With Hypertension
SGLT2 Inhibitors in MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) Associated with Sustained Hepatic Benefits, Besides the Cardiometabolic
Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes
Association Between High FIB-4 Score and the Risk of Malignancy Development and Mortality: A Retrospective Longitudinal Case-Control Study
Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway
NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression
Focused ethnography of nurses' interactions and behaviours in the therapeutic positioning of patients with traumatic brain injury in Pakistan: study protocol
Pediatric kidney replacement therapies in low-to-middle income countries: a review and white paper
Evaluating the influence of maternal anti-HBs status on the antibody levels in vaccinated children
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
Structural organization of the organic sheath that delineates extracellular seta silicification in diatoms
Breastfeeding practices and exclusive breastfeeding among syrian refugee mothers in Jordanian Host Communities
Is it beneficial to allow the patient's family to attend cardiac resuscitation: Different cultural perspectives? A scoping review
Rosuvastatin restores liver tissue-resident NK cell activation in aged mice by improving mitochondrial function
High-fat diet mouse model receiving L-glucose supplementations propagates liver injury
Dental students' perceptions of integrating online learning in the dental curriculum
A pH-Dependent Phase Separation Drives Polyamine-Mediated Silicification from Undersaturated Solutions
HCC TRANSPLANT CANDIDATES' SURVIVAL ON THE WAITING LIST - CAN ORGAN UTILIZATION BE IMPROVED?
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies
Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study
The liver in Greco-Arabic and Islamic medicine
TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
The Lymphatic Endothelial Cell Secretome Inhibits Osteoblast Differentiation and Bone Formation
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis
Patients with low ALT levels are at increased risk for severe COVID-19
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
The impact of obesity on postoperative complications and short-term survival after liver transplantation
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced Lipolysis
Cardiorenal syndrome in the pediatric population: A systematic review
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Missed Nursing Care in Medical and Surgical Wards in Jordan: A Cross-Sectional Study
SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
Effect of Age on Liver Transplantation Recipient Outcomes: Two Centers' Experience
Pulmonary embolism risk in hospitalized patients with nonalcoholic fatty liver disease: A case-control study
Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections
Postpartum depression among first-time Jordanian mothers: levels and associated factors
Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling
Streptococcus agalactiae imports spermidine by a member of the amino acid/polyamine antiporter family to endure citric acid stress at the vaginal pH
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality
Показать ещё 42 статьи Скрыть статьи
Заболевания
Гепатит С
Рак печени
Первичный билиарный холангит
Острая печеночная порфирия
Процедуры
Трансплантация печени
Биопсия печени
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы